With an improved median survival of 6.2 years, lung transplantation has become an
increasingly acceptable treatment option for end-stage lung disease. Besides survival …

Lung transplantation is the most effective therapy for patients with end-stage lung disease.
However, concern of donor lung damage and ischemia-reperfusion induced lung injury …

The outcomes of transplantation vary widely by organ. Lung transplantation (LTx) has rather
poor long-term outcome, with a current median post-transplant survival of 6.0 years. 1, 2 …

This 36th adult lung and heart-lung transplant report summarizes data from 69,200 adult
lung and 4,128 adult heart-lung transplants performed through June 30, 2018 and reported …

This 35th adult lung and heart-lung transplant report summarizes data from 64,803 adult
lung and 4,054 adult heart-lung transplants performed through June 30, 2017, and reported …

For over 30 years, the International Society for Heart and Lung Transplantation (ISHLT)
International Thoracic Organ Transplant (TTX) Registry has gathered data regarding …

Cold static preservation on ice (~ 4° C) remains the clinical standard of donor organ
preservation. However, mitochondrial injury develops during prolonged storage, which limits …

Importance The mortality rate for individuals on the wait list for lung transplant is 15% to
25%, and still only 20% of lungs from multiorgan donors are used for lung transplant. The …

Organ transplantation as an option to overcome end-stage diseases is common in countries
with advanced healthcare systems and is increasingly provided in emerging and developing …

Almost 70,000 adult lung transplant procedures have been reported to the International
Society for Heart and Lung Transplantation (ISHLT) International Thoracic Organ Transplant …